Transaction is anticipated to be completed in third quarter 2025 Planned Cortigent Nasdaq listing intended to drive value for ...

Cortigent is developing the Stroke Recovery System to improve the recovery of arm and hand movement in people who have suffered paralysis due to stroke Spin-off will allow Vivani to focus on its ...

Vivani’s CEO, Adam Mendelsohn, Ph.D., noted the importance of this milestone in establishing Cortigent as an independent entity dedicated to pioneering neurostimulation technology. Cortigent’s ...

Transaction is anticipated to be completed in third quarter 2025 Planned Cortigent Nasdaq listing intended to drive value for Vivani and Cortigent stockholders Cortigent is developing the Orion ...

ALAMEDA, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) ("Vivani” or the "Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting ...

Vivani Medical is developing GLP-1 subdermal implants that aim to provide a consistent therapeutic dose for six months, and ...

Fluent's Board of Advisors features a roster of distinguished industry veterans who have a proven track record in scaling high-growth businesses, pioneering digital transformation, and building ...

IPO content provided by Renaissance Capital LLC, manager of the IPO-focused ETFs (tickers: IPO, IPOs).

Olympus announced today that it received FDA 510(k) clearance for its EZ1500 series endoscopes featuring Extended Depth of Field (EDOF) technology. EDOF endoscopes (the GIF-EZ1500 gastroscope and ...